ACH-806

Investigational

CCCCCOC1=C(C=C(NC(=S)NC(=O)C2=CC=CN=C2)C=C1)C(F)(F)F

InChIKey=WJSGOXONRXFGRY-UHFFFAOYSA-N

InChI=1S/C19H20F3N3O2S/c1-2-3-4-10-27-16-8-7-14(11-15(16)19(20,21)22)24-18(28)25-17(26)13-6-5-9-23-12-13/h5-9,11-12H,2-4,10H2,1H3,(H2,24,25,26,28)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients.	2008-12	19026009
Synergy of a hepatitis C virus (HCV) NS4A antagonist in combination with HCV protease and polymerase inhibitors.	2008-05	18332167

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:02:42 GMT 2025` Edited by `admin` on `Mon Mar 31 18:02:42 GMT 2025`
Record UNII	290J0F5T07
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

GS-9132

Preferred Name

English

ACH-806

Common Name

English

3-PYRIDINECARBOXAMIDE, N-(((4-(PENTYLOXY)-3-(TRIFLUOROMETHYL)PHENYL)AMINO)THIOXOMETHYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

290J0F5T07

Created by admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025

PRIMARY

CAS

870142-71-5

Created by admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025

PRIMARY

PUBCHEM

11640186

Created by admin on Mon Mar 31 18:02:42 GMT 2025 , Edited by admin on Mon Mar 31 18:02:42 GMT 2025

PRIMARY